Posts

Showing posts from October, 2020

Human Respiratory Syncytial Virus (RSV) Treatment Market Anticipated to Grow at a CAGR of 12% by Emerging Trends, Share, Growth Rate, Opportunities And Market Forecast To 2027 - MENAFN.COM

Human Respiratory Syncytial Virus (RSV) Treatment Market Anticipated to Grow at a CAGR of 12% by Emerging Trends, Share, Growth Rate, Opportunities And Market Forecast To 2027    MENAFN.COM

Industry News: PerkinElmer receives CE Mark for multi-analyte respiratory panel including COVID-19 - SelectScience

Industry News: PerkinElmer receives CE Mark for multi-analyte respiratory panel including COVID-19    SelectScience

Will SARS-CoV-2 become endemic? - Science Magazine

Will SARS-CoV-2 become endemic?    Science Magazine

Codagenix, Inc. Appoints Jeffrey Fu, Ph.D., Chief Business Officer - PRNewswire

Codagenix, Inc. Appoints Jeffrey Fu, Ph.D., Chief Business Officer    PRNewswire

Will SARS-CoV-2 become endemic? - Science Magazine

Will SARS-CoV-2 become endemic?    Science Magazine

Codagenix, Inc. Appoints Jeffrey Fu, Ph.D., Chief Business Officer - Galveston County Daily News

Codagenix, Inc. Appoints Jeffrey Fu, Ph.D., Chief Business Officer    Galveston County Daily News

Codagenix, Inc. Appoints Jeffrey Fu, Ph.D., Chief Business Officer - Galveston County Daily News

Codagenix, Inc. Appoints Jeffrey Fu, Ph.D., Chief Business Officer    Galveston County Daily News

Will SARS-CoV-2 become endemic? - Science Magazine

Will SARS-CoV-2 become endemic?    Science Magazine

Codagenix, Inc. Appoints Jeffrey Fu, Ph.D., Chief Business Officer - PRNewswire

Codagenix, Inc. Appoints Jeffrey Fu, Ph.D., Chief Business Officer    PRNewswire

Flu activity still minimal in Wyoming; estimated 400K hospitalizations, 22K deaths in U.S. last season - Oil City News

Flu activity still minimal in Wyoming; estimated 400K hospitalizations, 22K deaths in U.S. last season    Oil City News

Informed consent disclosure to vaccine trial subjects of risk of COVID‐19 vaccines worsening clinical disease - Wiley

Informed consent disclosure to vaccine trial subjects of risk of COVID‐19 vaccines worsening clinical disease    Wiley

Children's respiratory disease warning - Bangkok Post

Children's respiratory disease warning    Bangkok Post

Children's respiratory disease warning - Bangkok Post

Children's respiratory disease warning    Bangkok Post

Informed consent disclosure to vaccine trial subjects of risk of COVID‐19 vaccines worsening clinical disease - Wiley

Informed consent disclosure to vaccine trial subjects of risk of COVID‐19 vaccines worsening clinical disease    Wiley

LabCorp revenue, earnings surge in Q3 - LabPulse

LabCorp revenue, earnings surge in Q3    LabPulse

COVID-19 containment measures affecting other seasonal respiratory viruses - News-Medical.Net

COVID-19 containment measures affecting other seasonal respiratory viruses    News-Medical.Net

Respiratory Syncytial Virus (RSV) Cards Market Slated to Grow at an Impressive CAGR of XX% During the Forecast Period 2018 – 2026 - Aerospace Journal

Respiratory Syncytial Virus (RSV) Cards Market Slated to Grow at an Impressive CAGR of XX% During the Forecast Period 2018 – 2026    Aerospace Journal

Bacteria-fighting cells in airways may boost infection risk - SelectScience

Bacteria-fighting cells in airways may boost infection risk    SelectScience

A new study offers detailed examination of United States RSV Diagnostics Market 2019-2025 - PRnews Leader

A new study offers detailed examination of United States RSV Diagnostics Market 2019-2025    PRnews Leader

Pfizer is on the verge of claiming a multibillion-dollar first-mover advantage with their Covid-19 vaccine — analyst - Endpoints News

Pfizer is on the verge of claiming a multibillion-dollar first-mover advantage with their Covid-19 vaccine — analyst    Endpoints News

Meissa Vaccines Expands Leadership Team as Company Advances Intranasal RSV and COVID-19 Live Attenuated Vaccine Candidates - Galveston County Daily News

Meissa Vaccines Expands Leadership Team as Company Advances Intranasal RSV and COVID-19 Live Attenuated Vaccine Candidates    Galveston County Daily News

Aridis Pharmaceuticals Announces $8.5 Million Registered Direct Offering - BioSpace

Aridis Pharmaceuticals Announces $8.5 Million Registered Direct Offering    BioSpace

Vaxart Announces Positive Hamster Challenge Study Data for its Oral COVID-19 Vaccine - GlobeNewswire

Vaxart Announces Positive Hamster Challenge Study Data for its Oral COVID-19 Vaccine    GlobeNewswire

Merck kicks back rights to early-phase RSV jab to Moderna - FierceBiotech

Merck kicks back rights to early-phase RSV jab to Moderna    FierceBiotech

Meissa Vaccines Expands Leadership Team as Company Advances Intranasal RSV and COVID-19 Live Attenuated Vaccine Candidates - Odessa American

Meissa Vaccines Expands Leadership Team as Company Advances Intranasal RSV and COVID-19 Live Attenuated Vaccine Candidates    Odessa American

Merck kicks back rights to early-phase RSV jab to Moderna - FierceBiotech

Merck kicks back rights to early-phase RSV jab to Moderna    FierceBiotech Moderna regains RSV vaccine programme from Merck    Pharmaceutical Technology Moderna Announces Updates on Respiratory Syncytial Virus (RSV) Vaccine Program | Vaccines | News Channels    PipelineReview.com Moderna regains RSV vaccine program; gets $56 million award    The Pharma Letter Moderna pushes forward on Respiratory Syncytial Virus vaccine    The Jerusalem Post View Full Coverage on Google News

AMA announces new CPT codes for tests aimed at detecting COVID-19 and flu - FierceHealthcare

AMA announces new CPT codes for tests aimed at detecting COVID-19 and flu    FierceHealthcare

BARDA and JPEO-CBRND Back Cepheid's Multiplex Test for Influenza, SARS-CoV2 and RSV - Global Biodefense

BARDA and JPEO-CBRND Back Cepheid's Multiplex Test for Influenza, SARS-CoV2 and RSV    Global Biodefense

Johnson & Johnson to supply EU with up to 400 million COVID-19 vaccine doses - BioPharma-Reporter.com

Johnson & Johnson to supply EU with up to 400 million COVID-19 vaccine doses    BioPharma-Reporter.com

Making a bed for viral infections - Science Magazine

Making a bed for viral infections    Science Magazine

Making a bed for viral infections - Science Magazine

Making a bed for viral infections    Science Magazine

Bacteria-fighting cells in airways boosts infection risk from viruses - Mirage News

Bacteria-fighting cells in airways boosts infection risk from viruses    Mirage News

Neutrophilic inflammation in the respiratory mucosa predisposes to RSV infection - Science

Neutrophilic inflammation in the respiratory mucosa predisposes to RSV infection    Science

Mother's gut instinct saved baby boy's life - HeraldScotland

Mother's gut instinct saved baby boy's life    HeraldScotland

Bacteria-fighting cells in the airways boost infection risk from viruses | Imperial News - Imperial College London

Bacteria-fighting cells in the airways boost infection risk from viruses | Imperial News    Imperial College London

Respiratory syncytial virus and influenza detections hit record low levels in 2020 - Medical Xpress

Respiratory syncytial virus and influenza detections hit record low levels in 2020    Medical Xpress

Airways Prepared To Fight Bacteria May Be Vulnerable to Viral Infections - Technology Networks

Airways Prepared To Fight Bacteria May Be Vulnerable to Viral Infections    Technology Networks

Moderna Announces Updates on Respiratory Syncytial Virus (RSV) Vaccine Program | Vaccines | News Channels - PipelineReview.com

Moderna Announces Updates on Respiratory Syncytial Virus (RSV) Vaccine Program | Vaccines | News Channels    PipelineReview.com

BARDA and JPEO-CBRND Back Cepheid's Multiplex Test for Influenza, SARS-CoV2 and RSV - Global Biodefense

BARDA and JPEO-CBRND Back Cepheid's Multiplex Test for Influenza, SARS-CoV2 and RSV    Global Biodefense

Bacteria-fighting cells may boost infection risk from respiratory viruses - The Hippocratic Post

Bacteria-fighting cells may boost infection risk from respiratory viruses    The Hippocratic Post

Merck kicks back rights to early-phase RSV jab to Moderna - FierceBiotech

Merck kicks back rights to early-phase RSV jab to Moderna    FierceBiotech

Merck kicks back rights to early-phase RSV jab to Moderna - FierceBiotech

Merck kicks back rights to early-phase RSV jab to Moderna    FierceBiotech

Merck kicks back rights to early-phase RSV jab to Moderna - FierceBiotech

Merck kicks back rights to early-phase RSV jab to Moderna    FierceBiotech

Flu vaccines are available | Local News - Daily Rocket Miner

Flu vaccines are available | Local News    Daily Rocket Miner

Merck returns rights to RSV vaccine to Moderna - Seeking Alpha

Merck returns rights to RSV vaccine to Moderna    Seeking Alpha

Making a bed for viral infections - Science Magazine

Making a bed for viral infections    Science Magazine

Making a bed for viral infections - Science Magazine

Making a bed for viral infections    Science Magazine

Other news to note for Oct. 8, 2020 | 2020-10-08 - BioWorld Online

Other news to note for Oct. 8, 2020 | 2020-10-08    BioWorld Online

Remdesivir targets a structurally analogous region of the Ebola virus and SARS-CoV-2 polymerases - pnas.org

Remdesivir targets a structurally analogous region of the Ebola virus and SARS-CoV-2 polymerases    pnas.org

China Gives Unproven Covid-19 Vaccines to Thousands, With Risks Unknown - The New York Times

China Gives Unproven Covid-19 Vaccines to Thousands, With Risks Unknown    The New York Times

China Gives Unproven Covid-19 Vaccines to Thousands, With Risks Unknown - The New York Times

China Gives Unproven Covid-19 Vaccines to Thousands, With Risks Unknown    The New York Times

6 things doctors can do to boost flu vaccination among children - American Medical Association

6 things doctors can do to boost flu vaccination among children    American Medical Association

State Representative Shares Story Of Daughter's Bout With RSV - News On 6

State Representative Shares Story Of Daughter's Bout With RSV    News On 6

BioGX BV Gets CE-IVD Mark for Coronavirus, Flu, RSV Combo Test - GenomeWeb

BioGX BV Gets CE-IVD Mark for Coronavirus, Flu, RSV Combo Test    GenomeWeb

National burden estimates of hospitalisations for acute lower respiratory infections due to respiratory syncytial virus in young children in 2019 among 58 countries: a modelling study. - Physician's Weekly

National burden estimates of hospitalisations for acute lower respiratory infections due to respiratory syncytial virus in young children in 2019 among 58 countries: a modelling study.    Physician's Weekly

Cepheid Receives Emergency Use Authorization For SARS-CoV-2, Flu A, Flu B and RSV Combination Test - BioSpace

Cepheid Receives Emergency Use Authorization For SARS-CoV-2, Flu A, Flu B and RSV Combination Test    BioSpace

Sauk County announces new COVID-19 death as area case numbers climb - WiscNews

Sauk County announces new COVID-19 death as area case numbers climb    WiscNews

State Representative Shares Story Of Daughter's Bout With RSV - news9.com KWTV

State Representative Shares Story Of Daughter's Bout With RSV    news9.com KWTV

National burden estimates of hospitalisations for acute lower respiratory infections due to respiratory syncytial virus in young children in 2019 among 58 countries: a modelling study. - Physician's Weekly

National burden estimates of hospitalisations for acute lower respiratory infections due to respiratory syncytial virus in young children in 2019 among 58 countries: a modelling study.    Physician's Weekly

Literature Review Explores Potential Neuroprotective Effects of Resveratrol - Psychiatry Advisor

Literature Review Explores Potential Neuroprotective Effects of Resveratrol    Psychiatry Advisor